Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels

Biochimica et Biophysica Acta - Biomembranes

Volumn 1669, Issue 1, 2005, Pages 69-74

  Ichikawa, Kanae ^a   Hikita, Tomoya ^a   Maeda, Noriyuki ^a,b   Yonezawa, Sei ^a   Takeuchi, Yoshito ^a   Asai, Tomohiro ^a   Namba, Yukihiro ^b   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Nippon Fine Chemical Co Ltd   (Japan)

Author keywords

Angiogenesis; Liposome; Photodynamic therapy (PDT); Polyethylene glycol (PEG); Targeting

Indexed keywords

ALANYLPROLYLARGINYLPROLYLGLYCINE; ALANYLPROLYLARGINYLPROLYLGLYCINE POLYETHYLENE GLYCOL BENZOPORPHYRIN; BENZOPORPHYRIN DERIVATIVE; LIPOSOME; PENTAPEPTIDE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

AIR SAC; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER INHIBITION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ISOLATION; DRUG TARGETING; ENDOTHELIUM CELL; LASER; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR; TUMOR GROWTH; TUMOR MODEL;

EID: 17444390144     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2005.02.003     Document Type: Article

References (25)

1. A.Z. Dudek, W.Z. Pawlak, and M.N. Kirstein Molecular targets in the inhibition of angiogenesis Expert Opin. Ther. Targets 7 2003 527 541
2. K. Shimizu, and N. Oku Cancer anti-angiogenic therapy Biol. Pharm. Bull. 27 2004 599 605
3. V.H. Fingar, P.K. Kik, P.S. Haydon, P.B. Cerrito, M. Tseng, E. Abang, and T.J. Wieman Analysis of acute vascular damage after photodynamic therapy using benzoporphyrin derivative (BPD) Br. J. Cancer 79 1999 1702 1708
4. Y. Takeuchi, K. Kurohane, K. Ichikawa, S. Yonezawa, M. Nango, and N. Oku Induction of intensive tumor suppression by anti-angiogenic photodynamic therapy using polycation-modified liposomal photosensitizer Cancer 97 2003 2027 2034
5. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng Photodynamic therapy J. Natl. Cancer Inst. 90 1998 889 905
6. K. Ichikawa, Y. Takeuchi, S. Yonezawa, T. Hikita, K. Kurohane, Y. Namba, and N. Oku Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth Cancer Lett. 205 2004 39 48
7. K. Kurohane, A. Tominaga, K. Sato, J.R. North, Y. Namba, and N. Oku Photodynamic therapy targeted to tumor-induced angiogenic vessels Cancer Lett. 167 2001 49 56
8. T. Ishida, H. Harashima, and H. Kiwada Liposome clearance Biosci. Rep. 22 2002 197 224
9. K. Ichikawa, T. Hikita, N. Maeda, Y. Takeuchi, Y. Namba, and N. Oku PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy Biol. Pharm. Bull. 27 2004 443 444
10. N. Oku, T. Asai, K. Watanabe, K. Kuromi, M. Nagatsuka, K. Kurohane, H. Kikkawa, K. Ogino, M. Tanaka, D. Ishikawa, H. Tsukada, M. Momose, J. Nakayama, and T. Taki Anti-neovascular therapy using novel peptides homing to angiogenic vessels Oncogene 21 2002 2662 2669
11. T. Asai, K. Shimizu, M. Kondo, K. Kuromi, K. Watanabe, K. Ogino, T. Taki, S. Shuto, A. Matsuda, and N. Oku Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels FEBS Lett. 520 2002 167 170
12. N. Maeda, Y. Takeuchi, M. Takada, Y. Sadzuka, Y. Namba, and N. Oku Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome J. Control. Release 100 2004 41 52
13. N. Maeda, Y. Takeuchi, M. Takada, Y. Namba, and N. Oku Synthesis of angiogenesis-targeted peptides and hydrophobized polyethylene glycol conjugate Bioorg. Med. Chem. Lett. 14 2004 1015 1017
14. M.R. Hamblin, J.L. Miller, I. Rizvi, H.G. Loew, and H.T. Hasan Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy Br. J. Cancer 89 2003 937 943
15. O. Bourdon, I. Laville, D. Carrez, A. Croisy, P. Fedel, A. Kasselouri, P. Prognon, P. Legrand, and J. Blais Biodistribution of meta-tetra(hydroxyphenyl) chlorin incorporated into surface-modified nanocapsules in tumor-bearing mice Photochem. Photobiol. Sci. 1 2002 709 714
16. N. Oku, Y. Tokudome, T. Asai, and H. Tsukada Evaluation of drug targeting strategies and liposomal trafficking Curr. Pharm. Des. 6 2000 1669 1691
17. H. Maeda, J. Fang, T. Inutsuka, and Y. Kitamoto Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications Int. Immunopharmacol. 3 2003 319 328
18. J. Fang, T. Sawa, and H. Maeda Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS Adv. Exp. Med. Biol. 519 2003 29 49
19. D.E. Dolmans, A. Kadambi, J.S. Hill, C.A. Waters, B.C. Robinson, J.P. Walker, D. Fukumura, and R.K. Jain Vascular accumulation of a novel photosensitizer, MV6401, causes selective thrombosis in tumor vessels after photodynamic therapy Cancer Res. 62 2002 2151 2156
20. D.E. Dolmans, A. Kadambi, J.S. Hill, K.R. Flores, J.N. Gerber, J.P. Walker, I.H. Rinkes, R.K. Jain, and D. Fukumura Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy Cancer Res. 62 2002 4289 4294
21. Y. Takeuchi, K. Kurohane, K. Ichikawa, S. Yonezawa, H. Ori, T. Koishi, M. Nango, and N. Oku Polycation liposome enhances the endocytic uptake of photosensitizer into cells in the presence of serum Bioconj. Chem. 74 2003 790 796
22. Y. Takeuchi, K. Ichikawa, S. Yonezawa, K. Kurohane, T. Koishi, M. Nango, Y. Namba, and N. Oku Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome J. Control. Release 97 2004 231 240
23. F. Pastorino, C. Brignole, D. Marimpietri, M. Cilli, C. Gambini, D. Ribatti, R. Longhi, T.M. Allen, A. Corti, and M. Ponzoni Vascular damage and antiangiogenic effects of tumor vessel-targeted liposomal chemotherapy Cancer Res. 63 2003 7400 7409
24. R.M. Schiffelers, G.A. Koning, T.L. ten Hagen, M.H. Fens, A.J. Schraa, A.P. Janssen, R.J. Kok, G. Molema, and G. Storm Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 2003 115 122
25. M. Kondo, T. Asai, Y. Katanasaka, Y. Sadzuka, H. Tsukada, K. Ogino, T. Taki, K. Baba, and N. Oku Anti-neovascular therapy by liposomal drug targeted to membrane type-1 matrix metalloproteinase Int. J. Cancer 108 2004 301 306